Industry
Pharmaceuticals
Topic
IPOs
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
IPOs in Pharmaceuticals
... shares of common stock will be issued in the offering. In addition, Achieve has granted the underwriters a 45-day option to purchase up to 450,000 ...
... Calliditas has filed to raise SEK 650 million ($75 million) through an IPO ...
... venture funding and was approved by the FDA after two failed attempts. Valeant agreed to buy Sprout for $1 billion in cash in August 2015. ...
... CONSHOHOCKEN, Pa., June 05, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq:MDGL), a clinical-stage biopharmaceutical company focused on the development and commercialization ...
... Tricida has filed to raise $150 million to bring a chronic kidney disease ...
... Bermuda and Lexington, Massachusetts-based Kiniksa Pharmaceuticals, a biopharmaceutical company, has raised about $152.6 million for its IPO ...
... issue, our staff published some captivating, long-form features, including ones on Amazon, Pfizer, and Xerox. One I want to bring to your attention as it's ...
... Ardelyx, Inc. (Nasdaq: ARDX), today announced that it has commenced an underwritten public offering ...
... NEW HAVEN, Conn., May 21, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to ...
... also plan to launch WAYLIVRA, assuming approval. The commercialization of these two Ionis drugs will solidify Ionis as a multi-product, profitable company delivering innovative antisense ...
Subscribe now for full coverage on IPOs in Pharmaceuticals
Start My Free Trial